Login
From:
Multiple Sclerosis News Today
(Uncensored)
subscribe
1st Abata Candidate Is Treatment ABA-101 for Progressive MS | Now in Early Studies, MS Therapy Expected to Enter Trials in 2024 | Multiple Sclerosis News Today
https://multiplesclerosisnewstoday.com/news-posts/2022/12/15/1st-abata-candidate-aba-101-t-cell-treatment-progressive-ms/
links
backlinks
Tagged with:
progressive ms
Abata Therapeutics has chosen its first treatment candidate for development: the T-cell therapy ABA-101 for certain forms of progressive MS.
Roast topics
Find topics
Find it!
